0002-6145-11 |
0002-6145 |
HUMAN PRESCRIPTION DRUG |
Baqsimi |
glucagon |
POWDER |
NASAL |
20190806 |
N/A |
NDA |
NDA210134 |
Eli Lilly and Company |
GLUCAGON |
3 mg/1 |
1 TUBE in 1 CARTON (0002-6145-11) / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01) |
0002-6145-27 |
0002-6145 |
HUMAN PRESCRIPTION DRUG |
Baqsimi |
glucagon |
POWDER |
NASAL |
20190806 |
N/A |
NDA |
NDA210134 |
Eli Lilly and Company |
GLUCAGON |
3 mg/1 |
2 TUBE in 1 CARTON (0002-6145-27) / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01) |
0548-8352-02 |
0548-8352 |
HUMAN PRESCRIPTION DRUG |
Baqsimi |
glucagon |
POWDER |
NASAL |
20240207 |
N/A |
NDA |
NDA210134 |
Amphastar Pharmaceuticals, Inc. |
GLUCAGON |
3 mg/1 |
2 TUBE in 1 CARTON (0548-8352-02) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE |
0548-8351-01 |
0548-8351 |
HUMAN PRESCRIPTION DRUG |
Baqsimi |
glucagon |
POWDER |
NASAL |
20240315 |
N/A |
NDA |
NDA210134 |
Amphastar Pharmaceuticals, Inc. |
GLUCAGON |
3 mg/1 |
1 TUBE in 1 CARTON (0548-8351-01) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE |